Inari Medical, Inc. reaffirmed revenue guidance for the full year 2022. For the year, company reaffirming revenue guidance range of $360 million to $370 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.03 USD | +0.10% | +9.40% | -35.26% |
05-01 | Inari Medical Shares Jump on Higher Q1 Revenue | MT |
04-30 | Transcript : Inari Medical, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.26% | 2.44B | |
+73.37% | 12.38B | |
-17.09% | 7.99B | |
+16.88% | 7.21B | |
+3.57% | 5.79B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.17B | |
+3.09% | 2.03B | |
+4.85% | 1.88B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Reaffirms Revenue Guidance for the Full Year 2022